Monica Perea Velez
Director, CMC Advocacy and Policy, GSK
20 years experience in vaccines CMC R&D, working in Development, Quality and CMC regulatory . Currently director of CMC Policy for GSK. Leads the vaccines Europe and IFPMA Manufacturing and Quality teams. Is also EFPIA lead on General Pharmaceutical Legislation Annex II and the co lead of the EFPIA CMC Variations team.